Results 111 to 120 of about 630 (156)
Some of the next articles are maybe not open access.
Clinical Therapeutics, 2003
Reports of resistance and intolerance to currently available antifungal agents are increasing. Voriconazole is a broad-spectrum azole antifungal agent structurally derived from fluconazole. It is indicated for the treatment of invasive aspergillosis and serious fungal infections caused by Scedosporium apiospermum and Fusarium species in patients who ...
LilyAnn, Jeu +3 more
openaire +2 more sources
Reports of resistance and intolerance to currently available antifungal agents are increasing. Voriconazole is a broad-spectrum azole antifungal agent structurally derived from fluconazole. It is indicated for the treatment of invasive aspergillosis and serious fungal infections caused by Scedosporium apiospermum and Fusarium species in patients who ...
LilyAnn, Jeu +3 more
openaire +2 more sources
Pharmacoeconomics of voriconazole
Expert Opinion on Pharmacotherapy, 2010The recent increase in the use of antineoplastic and immune suppressive agents and the use of broad-spectrum antibiotics, prosthetic interventions, organ transplants and more aggressive surgery have been related to a greater prevalence of invasive fungal infections (IFI).
Carlos, Rubio-Terrés, Santiago, Grau
openaire +2 more sources